USANA HEALTH SCIENCES INC (USNA) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:USNA - US90328M1071 - Common Stock
21.93 USD
+0.33 (+1.53%)
21.93 USD
0 (0%)
Taking everything into account, USNA scores 5 out of 10 in our fundamental rating. USNA was compared to 36 industry peers in the Personal Care Products industry. USNA has an excellent financial health rating, but there are some minor concerns on its profitability. USNA is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- In the past year USNA was profitable.
- USNA had a positive operating cash flow in the past year.
- In the past 5 years USNA has always been profitable.
- In the past 5 years USNA always reported a positive cash flow from operatings.
1.2 Ratios
- With a Return On Assets value of 2.34%, USNA perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
- With a decent Return On Equity value of 3.22%, USNA is doing good in the industry, outperforming 63.89% of the companies in the same industry.
- With a Return On Invested Capital value of 4.04%, USNA perfoms like the industry average, outperforming 52.78% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for USNA is in line with the industry average of 11.85%.
- The 3 year average ROIC (10.32%) for USNA is well above the current ROIC(4.04%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.34% | ||
| ROE | 3.22% | ||
| ROIC | 4.04% |
ROA(3y)9.11%
ROA(5y)13.39%
ROE(3y)12.23%
ROE(5y)18.88%
ROIC(3y)10.32%
ROIC(5y)15.36%
1.3 Margins
- USNA has a Profit Margin (1.86%) which is in line with its industry peers.
- In the last couple of years the Profit Margin of USNA has declined.
- USNA has a Operating Margin of 4.58%. This is comparable to the rest of the industry: USNA outperforms 52.78% of its industry peers.
- USNA's Operating Margin has declined in the last couple of years.
- USNA has a Gross Margin of 79.18%. This is amongst the best in the industry. USNA outperforms 94.44% of its industry peers.
- USNA's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.58% | ||
| PM (TTM) | 1.86% | ||
| GM | 79.18% |
OM growth 3Y-18.51%
OM growth 5Y-10.85%
PM growth 3Y-20.58%
PM growth 5Y-12.29%
GM growth 3Y-0.21%
GM growth 5Y-0.29%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), USNA is creating some value.
- Compared to 1 year ago, USNA has less shares outstanding
- The number of shares outstanding for USNA has been reduced compared to 5 years ago.
- Compared to 1 year ago, USNA has a worse debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 3.80 indicates that USNA is not in any danger for bankruptcy at the moment.
- USNA has a better Altman-Z score (3.80) than 72.22% of its industry peers.
- There is no outstanding debt for USNA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.8 |
ROIC/WACC0.47
WACC8.63%
2.3 Liquidity
- USNA has a Current Ratio of 2.23. This indicates that USNA is financially healthy and has no problem in meeting its short term obligations.
- USNA has a Current ratio of 2.23. This is comparable to the rest of the industry: USNA outperforms 55.56% of its industry peers.
- USNA has a Quick Ratio of 1.46. This is a normal value and indicates that USNA is financially healthy and should not expect problems in meeting its short term obligations.
- USNA's Quick ratio of 1.46 is in line compared to the rest of the industry. USNA outperforms 58.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.23 | ||
| Quick Ratio | 1.46 |
3. Growth
3.1 Past
- USNA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -30.74%.
- Measured over the past years, USNA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -10.07% on average per year.
- Looking at the last year, USNA shows a small growth in Revenue. The Revenue has grown by 5.88% in the last year.
- The Revenue has been decreasing by -4.23% on average over the past years.
EPS 1Y (TTM)-30.74%
EPS 3Y-23.07%
EPS 5Y-10.07%
EPS Q2Q%-126.79%
Revenue 1Y (TTM)5.88%
Revenue growth 3Y-10.36%
Revenue growth 5Y-4.23%
Sales Q2Q%6.88%
3.2 Future
- USNA is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.69% yearly.
- The Revenue is expected to grow by 3.25% on average over the next years.
EPS Next Y-32.13%
EPS Next 2Y-13.66%
EPS Next 3Y2.69%
EPS Next 5YN/A
Revenue Next Year8.25%
Revenue Next 2Y3.22%
Revenue Next 3Y3.25%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 11.19 indicates a reasonable valuation of USNA.
- 83.33% of the companies in the same industry are more expensive than USNA, based on the Price/Earnings ratio.
- Compared to an average S&P500 Price/Earnings ratio of 27.38, USNA is valued rather cheaply.
- A Price/Forward Earnings ratio of 11.32 indicates a reasonable valuation of USNA.
- Based on the Price/Forward Earnings ratio, USNA is valued cheaper than 83.33% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of USNA to the average of the S&P500 Index (24.29), we can say USNA is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.19 | ||
| Fwd PE | 11.32 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, USNA is valued cheaper than 97.22% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 3.99 |
4.3 Compensation for Growth
- USNA has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.66%
EPS Next 3Y2.69%
5. Dividend
5.1 Amount
- USNA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
21.93
+0.33 (+1.53%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)01-12 2026-01-12/amc
Earnings (Next)04-20 2026-04-20/amc
Inst Owners61.98%
Inst Owner Change-0.51%
Ins Owners0.6%
Ins Owner Change0.02%
Market Cap400.88M
Revenue(TTM)912.67M
Net Income(TTM)16.99M
Analysts43.33
Price Target39.78 (81.4%)
Short Float %5.61%
Short Ratio2.25
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-48.47%
Min EPS beat(2)-131.29%
Max EPS beat(2)34.35%
EPS beat(4)3
Avg EPS beat(4)-16.63%
Min EPS beat(4)-131.29%
Max EPS beat(4)34.35%
EPS beat(8)6
Avg EPS beat(8)1.98%
EPS beat(12)9
Avg EPS beat(12)11.42%
EPS beat(16)9
Avg EPS beat(16)5.45%
Revenue beat(2)1
Avg Revenue beat(2)-1.82%
Min Revenue beat(2)-6.39%
Max Revenue beat(2)2.74%
Revenue beat(4)3
Avg Revenue beat(4)-0.68%
Min Revenue beat(4)-6.39%
Max Revenue beat(4)2.74%
Revenue beat(8)4
Avg Revenue beat(8)-1.55%
Revenue beat(12)7
Avg Revenue beat(12)-0.45%
Revenue beat(16)8
Avg Revenue beat(16)-1.17%
PT rev (1m)0%
PT rev (3m)-36.07%
EPS NQ rev (1m)0%
EPS NQ rev (3m)8.11%
EPS NY rev (1m)0%
EPS NY rev (3m)-33.97%
Revenue NQ rev (1m)-0.26%
Revenue NQ rev (3m)0.21%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-3.63%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.19 | ||
| Fwd PE | 11.32 | ||
| P/S | 0.44 | ||
| P/FCF | N/A | ||
| P/OCF | 12.72 | ||
| P/B | 0.76 | ||
| P/tB | 1.63 | ||
| EV/EBITDA | 3.99 |
EPS(TTM)1.96
EY8.94%
EPS(NY)1.94
Fwd EY8.84%
FCF(TTM)-10.1
FCFYN/A
OCF(TTM)1.72
OCFY7.86%
SpS49.93
BVpS28.89
TBVpS13.44
PEG (NY)N/A
PEG (5Y)N/A
Graham Number35.69
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.34% | ||
| ROE | 3.22% | ||
| ROCE | 6.88% | ||
| ROIC | 4.04% | ||
| ROICexc | 5.3% | ||
| ROICexgc | 13.62% | ||
| OM | 4.58% | ||
| PM (TTM) | 1.86% | ||
| GM | 79.18% | ||
| FCFM | N/A |
ROA(3y)9.11%
ROA(5y)13.39%
ROE(3y)12.23%
ROE(5y)18.88%
ROIC(3y)10.32%
ROIC(5y)15.36%
ROICexc(3y)25.77%
ROICexc(5y)39.61%
ROICexgc(3y)41.63%
ROICexgc(5y)58.84%
ROCE(3y)17.59%
ROCE(5y)26.19%
ROICexgc growth 3Y-27.3%
ROICexgc growth 5Y-19.15%
ROICexc growth 3Y-45.52%
ROICexc growth 5Y-31.11%
OM growth 3Y-18.51%
OM growth 5Y-10.85%
PM growth 3Y-20.58%
PM growth 5Y-12.29%
GM growth 3Y-0.21%
GM growth 5Y-0.29%
F-Score5
Asset Turnover1.26
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 973.94% | ||
| Cap/Sales | 23.69% | ||
| Interest Coverage | 62.89 | ||
| Cash Conversion | 49.24% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.23 | ||
| Quick Ratio | 1.46 | ||
| Altman-Z | 3.8 |
F-Score5
WACC8.63%
ROIC/WACC0.47
Cap/Depr(3y)569.36%
Cap/Depr(5y)383.35%
Cap/Sales(3y)9.41%
Cap/Sales(5y)6.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30.74%
EPS 3Y-23.07%
EPS 5Y-10.07%
EPS Q2Q%-126.79%
EPS Next Y-32.13%
EPS Next 2Y-13.66%
EPS Next 3Y2.69%
EPS Next 5YN/A
Revenue 1Y (TTM)5.88%
Revenue growth 3Y-10.36%
Revenue growth 5Y-4.23%
Sales Q2Q%6.88%
Revenue Next Year8.25%
Revenue Next 2Y3.22%
Revenue Next 3Y3.25%
Revenue Next 5YN/A
EBIT growth 1Y-49.2%
EBIT growth 3Y-26.96%
EBIT growth 5Y-14.62%
EBIT Next Year36.41%
EBIT Next 3Y21.21%
EBIT Next 5YN/A
FCF growth 1Y-347.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-62.96%
OCF growth 3Y-20.46%
OCF growth 5Y-13.6%
USANA HEALTH SCIENCES INC / USNA FAQ
What is the fundamental rating for USNA stock?
ChartMill assigns a fundamental rating of 5 / 10 to USNA.
Can you provide the valuation status for USANA HEALTH SCIENCES INC?
ChartMill assigns a valuation rating of 6 / 10 to USANA HEALTH SCIENCES INC (USNA). This can be considered as Fairly Valued.
Can you provide the profitability details for USANA HEALTH SCIENCES INC?
USANA HEALTH SCIENCES INC (USNA) has a profitability rating of 6 / 10.
What is the financial health of USANA HEALTH SCIENCES INC (USNA) stock?
The financial health rating of USANA HEALTH SCIENCES INC (USNA) is 7 / 10.
Can you provide the expected EPS growth for USNA stock?
The Earnings per Share (EPS) of USANA HEALTH SCIENCES INC (USNA) is expected to decline by -32.13% in the next year.